Active ingredientVindesineCat. No. P-V048-001CAS 59917-39-4Family · Pharmaceutical analytical standards
Vindesine
A semisynthetic vinca alkaloid that blocks tubulin and therefore cell division: developed in the 1970s, it is used with other chemotherapy drugs for leukaemias, lymphomas, melanoma and lung cancer. This family brings together the active ingredient and pharmacopoeial impurities.
Did you know?It comes from the Madagascar periwinkle (Catharanthus roseus), the ornamental plant that yields vinblastine and vincristine: vindesine is made by chemically modifying vinblastine.
Go to the active ingredient →Active ingredientVindesineCat. No. P-V048-001CAS 59917-39-4
Pharmacopoeial impurityDesacetylvinblastineCat. No. P-V048-002CAS 3352-69-0
Pharmacopoeial impurityVindesine EP Impurity CCat. No. P-V048-004CAS 55383-37-4No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceDesacetylvinblastine CRSEDQM code D0480000Family VindesineReference substanceVindesine sulfate CRSEDQM code V0500000Family VindesineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.